Skip to main content
. 2020 Jan 27;20:100308. doi: 10.1016/j.invent.2020.100308

Table 2.

Baseline demographic and clinical characteristics of the sample (N = 31).

Total sample Gothenburg (n = 13) London (n = 9) Brisbane (n = 9)
Gender, N (%)
 Girls 21 (67.7) 7 (53.9) 6 (66.7) 8 (88.9)
Age (years)
 Mean (SD), range 14.0 (2.3), 8–18 13.2 (2.6), 8–17 15.6 (2.0), 13–18 13.6 (1.2), 12–16
Distance to clinic (km)
 Median, range 16, 2–2435 14, 2–41 13, 2–438 1443, 9-2435a
Main contact person, N (%)
 Mother 25 (80.7) 8 (61.6) 8 (88.9) 10 (100)
Psychotropic medication for OCD, N (%)
 Previous 3 (9.7) 0 (0) 1 (11.1) 2 (22.2)
 Current 7 (22.6) 2 (15.4) 5 (55.6) 0 (0)
Previous psychological treatment, N (%)
 CBT for OCD 10 (41.9) 3 (23.1) 4 (44.4) 3 (33.3)
 CBT for other 4 (12.9) 0 (0) 1 (11.1) 3 (33.3)
 Other 4 (12.9) 1 (7.7) 1 (11.1) 2 (22.2)
Presence of comorbid diagnosis, N (%)
 Yes 17 (54.8) 5 (38.5) 5 (55.6) 7 (77.8)
Frequency of comorbid diagnosis, N (%)
 BDD 1 (3.2) 0 (0) 1 (11.1) 0 (0)
 Skin-picking disorder 1 (3.2) 1 (7.7) 0 (0) 0 (0)
 Specific phobia 8 (25.8) 2 (15.4) 0 (0) 6 (66.7)
 Social anxiety disorder 5 (16.1) 1 (7.7) 0 (0) 4 (44.4)
 Separation anxiety 1 (3.2) 0 (0) 1 (11.1) 0 (0)
 GAD 3 (9.7) 1 (7.7) 1 (11.1) 1 (11.1)
 Agoraphobia 1 (3.2) 1 (7.7) 0 (0) 0 (0)
 Depressive disorder 3 (9.7) 1 (7.7) 2 (22.2) 0 (0)
 Tic disorder 2 (6.5) 0 (0) 0 (0) 2 (22.2)
 ADHD 2 (6.5) 1 (7.7) 0 (0) 1 (11.1)
CY-BOCS total score
 Mean (SD), range 24.6 (3.5), 17–31 24.1 (3.2), 17–29 24.9 (4.7), 18–30 25.0 (2.9), 21–31
Referral source
 Clinician-referred 25 (80.1) 13 (100) 9 (100) 3 (33.3)a

Note: Site differences were calculated with a Bonferroni-corrected analysis. Subscripts (a) indicates a significant difference from the other sites.

Abbreviations: ADHD, Attention Deficit/Hyperactivity Disorder; CY-BOCS, Children's Yale-Brown Obsessive-Compulsive Scale.